| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.23 |
0.0001 |
| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |